Bioxytran

(OTC) BIXT

Current Price$0.03

Market Cap$3.05M

Since IPO (2018)-90%

5 Year+2,980%

1 Year-77%

1 Month-11%

Bioxytran Financials at a Glance

Market Cap

$3.05M

Revenue (TTM)

$0.00

Net Income (TTM)

-$2.84M

EPS (TTM)

-$0.03

P/E Ratio

-1.17

Dividend

$0.00

Beta (Volatility)

-0.84 (Low)

Dividend

$0.00

Beta (Volatility)

-0.84 (Low)

Price

$0.03

Volume

29,211

Open

$0.03

Price

$0.03

Volume

29,211

Open

$0.03

Previous Close

$0.03

Daily Range

$0.03 - $0.03

52-Week Range

$0.03 - $0.15

Estimated Earnings Date

Apr 15, 2026

Dividend

$0.00

Beta (Volatility)

-0.84 (Low)

Price

$0.03

Volume

29,211

Open

$0.03

Previous Close

$0.03

Daily Range

$0.03 - $0.03

52-Week Range

$0.03 - $0.15

Estimated Earnings Date

Apr 15, 2026

BIXT News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Bioxytran

Industry

Biotechnology

Sector

Health Care

Employees

CEO

David Platt, PhD

Website

www.bioxytraninc.com

Headquarters

Newton, MA 02464, US

BIXT Financials

Key Financial Metrics (TTM)

Gross Margin

Operating Margin

Net Income Margin

Return on Equity

Return on Capital

74%

Return on Assets

-5%

Earnings Yield

-85.47%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$3.05M

Shares Outstanding

98.90M

Volume

29.21K

Avg. Volume

293.23K

Financials (TTM)

Gross Profit

-$11.54K

Operating Income

-$1.85M

EBITDA

-$1.84M

Operating Cash Flow

-$526.46K

Capital Expenditure

$5.00

Free Cash Flow

-$526.46K

Cash & ST Invst.

$509.91K

Total Debt

$855.00K

Bioxytran Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q1 2026YOY CHG

Revenue

$0.00

N/A

Gross Profit

-$2.11K

-13.9%

Gross Margin

0.00%

N/A

Market Cap

$3.05M

N/A

Market Cap/Employee

$1.02M

N/A

Employees

N/A

Net Income

-$2.07M

-52.8%

EBITDA

-$1.93M

-46.5%

Quarterly Fundamentals

Name

Q1 2026YOY CHG

Net Cash

-$391.95K

+68.8%

Accounts Receivable

$0.00

N/A

Inventory

$0.00

N/A

Long Term Debt

$0.00

N/A

Short Term Debt

$855.00K

-32.2%

Return on Assets

-4.61%

N/A

Return on Invested Capital

74.45%

N/A

Free Cash Flow

-$238.61K

-42.6%

Operating Cash Flow

-$238.61K

-42.6%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

BVAXFBioVaxys Technology Corp.

BVAXFBioVaxys Technology Corp.$0.11-39.61%

KNBIFKane Biotech Inc.

KNBIFKane Biotech Inc.$0.03+16.51%

BZYRBurzynski Research Institute, Inc.

BZYRBurzynski Research Institute, Inc.$0.01+14.44%

CPMVMosaic ImmunoEngineering Inc.

CPMVMosaic ImmunoEngineering Inc.$0.69+3.03%

THERTheralink Technologies, Inc.

THERTheralink Technologies, Inc.$0.00+0.00%

NSHSFNanoSphere Health Sciences Inc.

NSHSFNanoSphere Health Sciences Inc.$0.00-57.29%

BETRFBetterLife Pharma Inc.

BETRFBetterLife Pharma Inc.$0.04+0.47%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

INHDInno

INHDInno$20.97+18.97%

SUNESUNation Energy

SUNESUNation Energy$4.19+2.71%

NPTTexxon

NPTTexxon$9.92+6.69%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$40.67-0.06%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$77.25+0.06%

SOFISoFi Technologies

SOFISoFi Technologies$16.57+0.03%

KEELKeel Infrastructure

KEELKeel Infrastructure$5.69+0.11%

Questions About BIXT

What is the current price of Bioxytran?

Bioxytran is trading at $0.03 per share.

What is the 52-week range for Bioxytran?

Over the past 52 weeks, Bioxytran has traded between $0.03 and $0.15.

How much debt does Bioxytran have?

As of the most recent reporting period, Bioxytran reported total debt of $1.21M.

How much cash does Bioxytran have on hand?

Bioxytran reported $463.05K in cash and cash equivalents in its most recent financial results.

What is Bioxytran’s dividend yield?

Bioxytran does not currently have a dividend yield.

Bioxytran

Bioxytran Financials at a Glance

BIXT News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Bioxytran

BIXT Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Bioxytran Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About BIXT

What is the current price of Bioxytran?

What is the 52-week range for Bioxytran?

How much debt does Bioxytran have?

How much cash does Bioxytran have on hand?

What is Bioxytran’s dividend yield?

Premium Investing Services